Pricing Strategy Overhaul for a Pharma Portfolio
A mid-size pharmaceutical company was leaving significant margin on the table across its specialty portfolio due to fragmented pricing logic and absent value communication to payers.
Comprehensive value-based pricing audit across 14 SKUs, payer landscape analysis, competitive price benchmarking, and a revised commercial strategy with tiered access models and health-economic evidence packs.
Key outcomes
Related case studies
DACH Market Entry for a US SaaS Company
A fast-growing US B2B SaaS firm lacked the market intelligence, local network, and GTM architecture to enter the German-speaking market effectively.
Competitive Strategy Reset for a Global Manufacturer
A century-old industrial manufacturer was losing share in three core segments to digital-native competitors with lower cost structures and faster product cycles.
Brand Repositioning for a Heritage Publisher
A 40-year-old business media brand was struggling for relevance with a new generation of decision-makers who consumed intelligence differently and distrusted traditional publishing.
Have a challenge worth solving?
Every engagement starts with a conversation. Submit your brief, tender, or question — we review every submission within 3 business days.